Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -108,159 | -73,955 | -46,734 | -19,519 | -47,664 |
| Depreciation Amortization | 7,513 | 5,227 | 3,197 | 1,439 | 2,892 |
| Income taxes - deferred | -375 | -734 | -734 | -716 | -4,373 |
| Accounts receivable | 2,344 | -562 | 1,406 | 287 | -1,434 |
| Accounts payable and accrued liabilities | 305 | -4,311 | -941 | -3,084 | 5,264 |
| Other Working Capital | -7,929 | -11,822 | -7,322 | -10,789 | -4,455 |
| Other Operating Activity | 6,237 | 11,127 | 3,119 | 4,364 | 154 |
| Operating Cash Flow | $-100,064 | $-75,030 | $-48,009 | $-28,018 | $-49,616 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -231,300 | -295,415 | -195,135 | -59,113 | -105,576 |
| PPE Investments | -2,933 | -1,764 | -1,077 | -603 | 3,607 |
| Investing Cash Flow | $-234,233 | $-297,179 | $-196,212 | $-59,716 | $-101,969 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 422,776 | 421,291 | 252,413 | 253,744 | 277 |
| Common Stock Repurchased | N/A | N/A | -5 | N/A | -45 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 98,426 |
| Financing Cash Flow | $422,776 | $421,291 | $252,408 | $253,744 | $98,658 |
| Beginning Cash Position | 16,873 | 16,873 | 16,873 | 16,873 | 69,800 |
| End Cash Position | 105,352 | 65,955 | 25,060 | 182,883 | 16,873 |
| Net Cash Flow | $88,479 | $49,082 | $8,187 | $166,010 | $-52,927 |
| Free Cash Flow | |||||
| Operating Cash Flow | -100,064 | -75,030 | -48,009 | -28,018 | -49,616 |
| Capital Expenditure | -2,933 | -1,764 | -1,077 | -603 | -2,589 |
| Free Cash Flow | -102,997 | -76,794 | -49,086 | -28,621 | -52,205 |